Comparison Between Steroid and Different Sites of Botulinum Toxin Injection in the Treatment of Lateral Epicondylalgia

NCT02767635 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2016-05-10

No results posted yet for this study

Summary

The aim of the study is to compare two different injection sites of low dose botulinum toxin type A with steroid in treating lateral epicondylalgia.

Conditions

  • Tennis Elbow

Interventions

DRUG

Botox-Epic

injected 20 units of Botox into lateral epicondyle in Botox-Epic group

DRUG

Botox-Tend

injected 20 units of Botox into tender point of muscles in Botox-Tend group

DRUG

triamcinolone acetonide (Steroid)

injected 40mg of triamcinolone acetonide into lateral epicondyle in Steroid group

Sponsors & Collaborators

  • National Cheng-Kung University Hospital

    lead OTHER

Principal Investigators

  • Yu-Ching Lin, MD, MSc · National Cheng-Kung University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02767635 on ClinicalTrials.gov